Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
View up-to-date information on SpringWorks Therapeutics Inc patents, including inventor and filing insights.
Patent Trends
| Publication Identifier | Document Type | Title | Classification-CPC | Publication Date |
|---|---|---|---|---|
| WO2023122780A9 | Search Report | 2-pyrazole anilines and related analogs for inhibiting yap/taz-tead | A61P35/00; C07B2200/09; C07D207/09; C07D213/16; C07D213/40; C07D213/56; C07D213/64; C07D213/84; C07D231/12; C07D249/06; C07D255/02; C07D257/04; C07D401/04; C07D401/06; C07D401/10; C07D401/14; C07D403/04; C07D403/10; C07D403/14; C07D405/04; C07D405/06; C07D405/14; C07D409/14; C07D413/04; C07D413/14; C07D417/04; C07D471/04; C07D471/08 | November 30, 2023 |
| US20230372300A1 | Application | Treatments with nirogacestat | A61K31/4164; A61P35/00 | November 23, 2023 |
| WO2023225283A1 | Application | Treatments with nirogacestat | A61K31/4164; A61P35/00 | November 23, 2023 |
| US20230372301A1 | Application | Treatments with nirogacestat | A61K31/4164; A61P35/00 | November 23, 2023 |
| US11819487B2 | Grant | Treatment of neurofibromatosis type 1 (NF1) associated plexiform neurofibromas (PN) in pediatric patients with mirdametinib | A61K31/216; A61P35/00 | November 21, 2023 |
Top Inventors by Filings (Count by publication)
| Name | Count |
|---|
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer